Publications

Journal Article
Research Support, Non-U.S. Gov't
Ppublish 220 citations
Open access — free full text available
Open access
Electronic publication date
April 14, 2010

View on Pubmed.gov 20227366 | View on doi.org 10.1016/j.molce... | View the free full text Full text

Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl.

Search for publications in this journal Mol Cell - 37(5):607-19

Abstract

The mechanism by which Wnt receptors transduce signals to activate downstream beta-catenin-mediated target gene transcription remains incompletely understood but involves Frizzled (Fz) receptor-mediated plasma membrane recruitment and activation of the cytoplasmic effector Dishevelled (Dvl). Here, we identify the deubiquitinating enzyme CYLD, the familial cylindromatosis tumor suppressor gene, as a negative regulator of proximal events in Wnt/beta-catenin signaling. Depletion of CYLD from cultured cells markedly enhances Wnt-induced accumulation of beta-catenin and target gene activation. Moreover, we demonstrate hyperactive Wnt signaling in human cylindroma skin tumors that arise from mutations in CYLD. At the molecular level, CYLD interacts with and regulates K63-linked ubiquitination of Dvl. Enhanced ubiquitination of the polymerization-prone DIX domain in CYLD-deficient cells positively links to the signaling activity of Dvl. Together, our results argue that loss of CYLD instigates tumor growth in human cylindromatosis through a mechanism in which hyperubiquitination of polymerized Dvl drives enhancement of Wnt responses.

References

No references provided.

Cited by 220 citations (total)

Journal Article Research Support, Non-U.S. Gov't

The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate notch signalling.

Electronic publication date October 2, 2015

Search for publications in this journal Oncotarget

Neil Rajan [...] Alan Ashworth et al.

CYLD, an ubiquitin hydrolase, has an expanding repertoire of regulatory roles in cell signalling and is dysregulated in a number...

Journal Article Review

Deubiquitinases in cancer.

Electronic publication date April 14, 2016

Search for publications in this journal Oncotarget

Rongbin Wei [...] Shangfeng Liu et al.

Deubiquitinases are deubiquitinating enzymes (DUBs), which remove ubiquitin from proteins, thus regulating their proteasomal degradation, localization and activity. Here, we...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances

Copyright

(c) 2010 Elsevier Inc. All rights reserved.